The rest is here:
Cocrystal Pharma to Present at the H.C. Wainwright 6th Annual Israel Conference

Read more:
Atreca to Present at Upcoming Virtual Investor Conferences

Follow this link:
Crinetics Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Read this article:
Equillium Announces Positive Interim Data of Itolizumab in the First-line Treatment of Acute Graft-Versus-Host Disease

View original post here:
Aeterna Zentaris Reports Third Quarter 2020 Financial Results and Provides Business Update

More:
SCYNEXIS Reports Third Quarter 2020 Financial Results and Provides Company Update

Continue reading here:
Kannalife, Inc. Rebrands as Neuropathix, Inc. and Unveils New Ticker Symbol

The rest is here:
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020

Read the rest here:
Virbac : Declaration of the number of shares and voting rights October 2020

See the rest here:
Homology Medicines Announces Presentation of Positive Data from the Dose-Escalation Phase of the pheNIX Gene Therapy Trial for Adults with PKU

Link:
Tauriga Sciences, Inc. Experiencing Greater Market Acceptance for its Cannabis (CBD & CBG) Infused Chewing Gum Product Line

Read more from the original source:
Theratechnologies Announces that Data on the Mechanism of Effect of Tesamorelin in NAFLD will be Presented at The Liver Meeting® 2020

View original post here:
Summit Announces Closing of Private Placement of $50 Million

See more here:
Mustang Bio Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights

Here is the original post:
Monthly information on share capital and company voting rights

Read the original:
Braingrid Limited Announces Share Consolidation

Read more from the original source:
Obalon Announces Third Quarter 2020 Financial Results

See the original post:
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights

Originally posted here:
Golden Leaf Holdings Announces Resignation of President Stanley Grissinger

Link:
Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease